Validation of a tool for estimating clinician recognition of ARDS using data from the international LUNG SAFE study.

ABSTRACT: Under-recognition of acute respiratory distress syndrome (ARDS) by clinicians is an important barrier to adoption of evidence-based practices such as low tidal volume ventilation. The burden created by the COVID-19 pandemic makes it even more critical to develop scalable data-driven tools to improve ARDS recognition. The objective of this study was to validate a tool for accurately estimating clinician ARDS recognition rates using discrete clinical characteristics easily available in electronic health records. We conducted a secondary analysis of 2,705 ARDS and 1,261 non-ARDS hypoxemic patients in the international LUNG SAFE cohort. The primary outcome was validation of a tool that estimates clinician ARDS recognition rates from health record data. Secondary outcomes included the relative

SUBMITTER: Bechel MA 

PROVIDER: S-EPMC10456149 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature